It is very hard or impossible to time the broad market consistently — there are no famous investors that got rich by consistently knowing what the broad market would do next. This only makes sense, as there are just too many variables in the broad market. But there are many famous investors who got rich analyzing individual securities, and this is where you should put your focus. You can get an edge in individual securities. Joe Springer was the number 1 ranked stock analyst in the world by tipranks.com. Joe is a Certified Technical Trainer, and enjoys teaching about the stock market as well as managing portfolios. If you would like to follow Joe on Twitter, his handle is @JoeSpringer.
I am Seeking Alpha's CEO and Editor-in-Chief. My love for the stock markets goes back to when I was a kid. Who else remembers combing through the stock quotes at the back of the business section of your local paper?
I joined Seeking Alpha in 2006 and launched Wall Street Breakfast and Market Currents, our top-of-class short-form breaking news for investors. In 2010 I became editor-in-chief and in 2015 I became CEO.
I live in Jerusalem with my wife and a bunch of exceptional kids. Most days, you'll find me making the commute from Jerusalem to Raanana. Occasionally I get to work from my home-office, from where I keep an eye on the beautiful Judean Hills.
To contact me, send me a direct message, or email me at email@example.com.
Value Digger holds MSc. in Electrical Engineering, speaks four languages and has lived in the U.S. for many years. Also, he is a full-time investor and a freelance writer with one of the highest Followers per Article (F/A) rates in Seeking Alpha. His F/A rate in Seeking Alpha is above 30.
After creating "Nathan's Bulletin" (a subscription-based investment guide for investors who can't afford a financial advisor), Value Digger launched a subscription-based Premium Service in Seeking Alpha entitled "A Fundamental Investor's Stock Club" which includes an unparalleled, actively-managed and high-return Portfolio of unknown and/or underfollowed stocks. Regularly updated and detailed lists in his Premium Posts PROVE these high returns. For reference, when Value Digger was managing money in the early 2000s, his Portfolio's annual ROI consistently exceeded 50%. His Premium Research is based on a comprehensive review of company-specific factors, macro conditions, competitors and the industry trends.
When it comes to his publicly-available picks and his free Seeking Alpha articles, Value Digger is ranked in the TOP-50 with a success rate of over 70%, an average return per recommendation of over 20% and a 5-star rating according to TipRanks.com, which is the highest category quality ranking used to evaluate financial experts. TipRanks.com is a comprehensive investing tool that allows private investors and day traders to see the measured performance of anyone who publicly provides financial advice. TipRanks.com collects data, evaluates and ranks 9,000 financial experts worldwide.
After almost 30 years of investing experience in the international markets (U.S., Canada, Australia, Europe), Value Digger has formulated a deep understanding of valuation analysis and his investment philosophy is firmly grounded in Ben Graham-style value-oriented opportunities that often have an assymetric risk/reward profile. On that front, he has created a unique proprietary database with thousands of publicly-traded companies per sector, which helps him spot the bargains and the bubbles before many investors find them.
Fundamental, research-driven fund specializing in ADR, small-cap and distressed companies. Focused on intrinsic value in quality, growing companies along with specific catalysts that can cause share prices to recover.
John E. Fitzgibbon, Jr. has been following the IPO market since 1973 as an investment banker, as an analyst and as a journalist. In a CBS News survey, Mr. Fitzgibbon was named “The Best of Wall Street” for his coverage of IPOs. He has held the following registrations: Series 7; Series 8; Series 24 and Series 63.
BioShockers.com is a recently created biotech investing website that is focused on finding high-potential, low-price, and legitimate biotech/pharma companies.
The great majority of stocks we will do write-ups on will be on one of three exchanges, NASDAQ, AMEX, or NYSE. Occasionally, we will alert an OTC:BB stock only if we think it has promise. We will seldom alert pink sheet stocks here -- many of them are extremely volatile, and some illegitimate.
Before you open a position in any stock that we trade/alert, please read our disclaimer below:
BioShockers.com is not to be held responsible for any loss (or profit) associated with stocks mentioned. Under no circumstances will BioShockers.com be ...More held liable for losses incurred due to information presented anywhere on this site. The information we post on stocks is provided as an information service only - a starting point for your own research. The accuracy or completeness of the information we provide is not warranted and is only as reliable as the sources from which it was obtained. Do your own research before investing in any of the stocks mentioned on this website and consult with a financial/investment advisor. We are not licensed brokers or financial advisors of any kind. Be aware that you can lose all or part of your investment in any stock we alert.
We have never been compensated by anyone for stocks that we trade or alert.